Skip to content
Home/Companies/MedTech/Inhalation Sciences
IS

Inhalation Sciences

MedTech·Sweden·Active·13yr hold

Inhalation Sciences is a MedTech company, headquartered in Sweden.

Entry
2013
Hold
13yr
Status
Active
Est. EV
–

Who owns Inhalation Sciences?

Inhalation Sciences is currently owned by Rosetta Capital through Rosetta Capital IV (2013 vintage), since 2013.

Hand-verified · updated 2026-06-30

Rosetta Capital
Investor
Rosetta Capital
Rosetta Capital IV · 2013 · Secondaries

Key facts

HQSweden
SectorMedTech
StatusActive

More from Rosetta Capital IV

Other portfolio companies in the same fund.

Akinion Pharmaceuticals
Active
PharmaSweden· 2013
Aprea Therapeutics
Exited 2019
BiotechSweden· 2013
Axelar
Active
BiotechSweden· 2013
Biosergen
Exited 2021
BiotechSweden· 2013
Clanotech
Active
BiotechSweden· 2013
Dilafor
Active
BiotechSweden· 2013

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings